A notable example in our cohort was the identification of a BCORL1 mutation in a patient initially classified as lymphoma negative, prompting a re-evaluation of bone marrow aspirates and a revised diagnosis of marginal zone lymphoma [27,28]. The gene discussed is BCORL1; the disease is lymphoma.